Cargando…
Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672796/ https://www.ncbi.nlm.nih.gov/pubmed/35918981 http://dx.doi.org/10.4103/ijo.IJO_2985_21 |
_version_ | 1784832819559661568 |
---|---|
author | Sheth, Jay U Narayanan, Raja Anantharaman, Giridhar Bhende, Muna Agarwal, Aniruddha Chawla, Shobhit Rajendran, Anand |
author_facet | Sheth, Jay U Narayanan, Raja Anantharaman, Giridhar Bhende, Muna Agarwal, Aniruddha Chawla, Shobhit Rajendran, Anand |
author_sort | Sheth, Jay U |
collection | PubMed |
description | In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV evolves, retinal physicians must constantly modify their current practice. The current guidelines are based on the most up-to-date information on PCV and are an update to the previous set of guidelines. These guidelines were developed by a panel of Indian retinal experts under the aegis of the Vitreoretinal Society of India (VRSI), based on a comprehensive search and assessment of literature up to September 2021. The final guidelines i) provide the updated nomenclature in PCV; ii) discusses the newer diagnostic imaging features of PCV, especially in the absence of indocyanine green angiography (ICGA); and iii) recommends the best possible therapeutic approach in the management of PCV, including the choice of anti-vascular endothelial growth factor (anti-VEGF) agents, treatment regimen, and the role of switching between the anti-VEGF agents. In the face of non-availability of photodynamic therapy (PDT) in India, we constructed practical recommendations on anti-VEGF monotherapy in PCV. The current updated recommendations would provide a broader framework to the treating retinal physician for the diagnosis and management of PCV for optimal therapeutic outcomes. |
format | Online Article Text |
id | pubmed-9672796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-96727962022-11-19 Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India Sheth, Jay U Narayanan, Raja Anantharaman, Giridhar Bhende, Muna Agarwal, Aniruddha Chawla, Shobhit Rajendran, Anand Indian J Ophthalmol Consensus Criteria In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV evolves, retinal physicians must constantly modify their current practice. The current guidelines are based on the most up-to-date information on PCV and are an update to the previous set of guidelines. These guidelines were developed by a panel of Indian retinal experts under the aegis of the Vitreoretinal Society of India (VRSI), based on a comprehensive search and assessment of literature up to September 2021. The final guidelines i) provide the updated nomenclature in PCV; ii) discusses the newer diagnostic imaging features of PCV, especially in the absence of indocyanine green angiography (ICGA); and iii) recommends the best possible therapeutic approach in the management of PCV, including the choice of anti-vascular endothelial growth factor (anti-VEGF) agents, treatment regimen, and the role of switching between the anti-VEGF agents. In the face of non-availability of photodynamic therapy (PDT) in India, we constructed practical recommendations on anti-VEGF monotherapy in PCV. The current updated recommendations would provide a broader framework to the treating retinal physician for the diagnosis and management of PCV for optimal therapeutic outcomes. Wolters Kluwer - Medknow 2022-08 2022-07-29 /pmc/articles/PMC9672796/ /pubmed/35918981 http://dx.doi.org/10.4103/ijo.IJO_2985_21 Text en Copyright: © 2022 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Consensus Criteria Sheth, Jay U Narayanan, Raja Anantharaman, Giridhar Bhende, Muna Agarwal, Aniruddha Chawla, Shobhit Rajendran, Anand Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
title | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
title_full | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
title_fullStr | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
title_full_unstemmed | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
title_short | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
title_sort | updated guidelines for the management of polypoidal choroidal vasculopathy: recommendations from the indian polypoidal choroidal vasculopathy panel and the vitreoretinal society of india |
topic | Consensus Criteria |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672796/ https://www.ncbi.nlm.nih.gov/pubmed/35918981 http://dx.doi.org/10.4103/ijo.IJO_2985_21 |
work_keys_str_mv | AT shethjayu updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT narayananraja updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT anantharamangiridhar updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT bhendemuna updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT agarwalaniruddha updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT chawlashobhit updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT rajendrananand updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia |